Publicaciones en colaboración con investigadores/as de Complejo Hospitalario de Toledo (3)

2017

  1. Gemcitabine–erlotinib versus gemcitabine–erlotinib–capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish TTD Collaborative Group

    European Journal of Cancer, Vol. 75, pp. 73-82

2016

  1. Laminin-adherent versus suspension-non-adherent cell culture conditions for the isolation of cancer stem cells in the DAOY medulloblastoma cell line

    Tumor Biology, Vol. 37, Núm. 9, pp. 12359-12370

2012

  1. MRNA in situ hybridization (HistoSonda): A new diagnostic tool for HER2-Status in breast cancer-A multicentric spanish study

    Diagnostic Molecular Pathology, Vol. 21, Núm. 2, pp. 84-92